Final NIH budget for 2024 is essentially flat
Congress has given the National Institutes of Health (NIH) a 0.6% increase, to $47.1 billion, in a final 2024 spending bill that lawmakers are expected to approve in time to avert a partial government shutdown this weekend. And several policy directives opposed by researchers have been stripped from the legislation. The tiny, $300 million bump is only one-third of the $920 million increase requested by President Joe Biden, who has promised to sign the $1.2 trillion package covering six federal agencies, and it comes after years of generous increases for NIH. But it was no surprise: Once the president and Congress agr...
Source: ScienceNOW - March 21, 2024 Category: Science Source Type: news

Low-Dose RT Boost Wins Support for Young Patients With Early Breast Cancer
(MedPage Today) -- A low-dose radiotherapy (RT) boost to the tumor bed provided adequate control of breast cancer recurrence in younger patients with better cosmetic results as compared with a high-dose boost, long-term follow-up from a randomized... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 21, 2024 Category: Hematology Source Type: news

No OS Difference in Pancreatic Cancer With SABR vs Irreversible Electroporation
(MedPage Today) -- The use of either MRI-guided stereotactic ablative body radiotherapy (SABR) or CT-guided percutaneous irreversible electroporation after standard FOLFIRINOX chemotherapy did not result in any significant difference in overall... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 21, 2024 Category: Gastroenterology Source Type: news

Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
PHILADELPHIA, March 21, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced its upcoming presentations at the American... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 21, 2024 Category: Pharmaceuticals Tags: CCA FVT Source Type: news

Five things to know about colon cancer prevention and screening
For Colon Cancer Awareness Month, Yale digestive diseases expert Xavier Llor shares some things everyone should know about colorectal cancer. (Source: Yale Science and Health News)
Source: Yale Science and Health News - March 21, 2024 Category: Universities & Medical Training Source Type: news

Overlooked No More: Yvonne Barr, Who Helped Discover a Cancer-Causing Virus
A virologist, she worked with the pathologist Anthony Epstein, who died last month, in finding for the first time that a virus that could cause cancer. It ’s known as the Epstein-Barr virus. (Source: NYT Health)
Source: NYT Health - March 21, 2024 Category: Consumer Health News Authors: Delthia Ricks Tags: Barr, Yvonne (1932-2016) Research Viruses Deaths (Obituaries) Science and Technology Epstein, Anthony (1921-2024) Middlesex Hospital Ireland Australia England Source Type: news

Strawberries, kale and collard greens make government's 'dirty dozen' list of foods that are teaming with cancer-causing pesticides - these are the products you MUST wash before eating
The Environmental Working Group (EWG), based in Washington, DC, named its 'dirty dozen' this week - meaning they have been deemed the fruits and veg in the US laced with the most chemicals. (Source: the Mail online | Health)
Source: the Mail online | Health - March 21, 2024 Category: Consumer Health News Source Type: news

RNA deserves its own massive counterpart to the human genome project, researchers argue
This report is very much modeled on the NASEM report that initiated the Human Genome Project, ” completed in 2003, says Cheung, who wasn’t involved in the new report’s drafting. But as the report notes, “The RNome is much more complex ” than a genome. For one thing, frequent modifications to RNA mean there will be no fixed, reference sequence like the one researchers produced for the human genome. For a given RNA molecule, researchers will have to document “not only the sequence, but also the type and location of the modifica...
Source: ScienceNOW - March 21, 2024 Category: Science Source Type: news

Ribociclib + Nonsteroidal Aromatase Inhibitor Benefits Early Breast Cancer
THURSDAY, March 21, 2024 -- Ribociclib plus a nonsteroidal aromatase inhibitor (NSAI) significantly improves invasive disease-free survival among patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2024 Category: Pharmaceuticals Source Type: news

Survival 21 Percent a Year After ICU Discharge for Blood Cancer Patients
THURSDAY, March 21, 2024 -- For hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published online March 11 in Intensive Care... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 21, 2024 Category: Pharmaceuticals Source Type: news

Pembrolizumab With Chemoradiotherapy for Cervical Cancer Pembrolizumab With Chemoradiotherapy for Cervical Cancer
Dr Maurie Markman discusses a recent FDA approval for locally advanced cervical cancer.Medscape Oncology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - March 21, 2024 Category: Radiology Tags: Hematology-Oncology Commentary Source Type: news

Baldwin Fund tours Upstate, visits with researchers to learn about Fund ’s impact on breast cancer research
Upstate researches have been awarded more than $4 million from the Carol M. Baldwin Fund for Breast Cancer Research. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - March 21, 2024 Category: Universities & Medical Training Tags: News Source Type: news

New CRC Risk Prediction Model Outperforms Polyp-Based Model New CRC Risk Prediction Model Outperforms Polyp-Based Model
A comprehensive model that includes additional risk factors beyond previous polyp findings showed improved post-colonoscopy risk stratification for colorectal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 21, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news

Breast cancer breakthroughs as scientists develop AI tools that can predict treatment side effects AND spot tiny signs of disease that human doctors miss
New AI tested in the UK, France, and the Netherlands has been trained to predict lymphoedema in breast cancer patients up to three years after surgery and radiotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - March 21, 2024 Category: Consumer Health News Source Type: news

A Bacteria in the Mouth Might Speed Colon Cancers
THURSDAY, March 21, 2024 -- A germ commonly found in the human mouth can travel to colon tumors and appears to speed their growth, new research shows. The finding might lead to new insights into fighting colon cancer, which kills more than 52,000... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 21, 2024 Category: General Medicine Source Type: news